IONIS PHARMACEUT reported $-208019000 in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US USD 28.68M 115.33M
Alnylam Pharmaceuticals ALNY:US USD -188614000 146.01M
Arrowhead Research ARWR:US USD -42134000 41.7M
Astellas Pharma 4503:JP JPY 61.39B 25.36B
Biocryst Pharmaceuticals BCRX:US USD -46311000 28.87M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -84781000 22.62M
Esperion Therapeutics ESPR:US USD -42513000 890K
Exelixis EXEL:US USD -48078000 130.69M
Halozyme Therapeutics HALO:US USD 74.51M 6.07M
Intercept Pharmaceuticals ICPT:US USD -18024000 83.88M
Mirati Therapeutics MRTX:US USD -211723000 25.28M
Moderna Inc MRNA:US USD 1.58B 414M
Nektar Therapeutics NKTR:US USD -52469000 1.83M
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NOVN:VX USD 1.95B 219M
Omeros OMER:US USD -40138000 10.63M
Pfizer PFE:US USD 5.17B 4.24B
Ptc Therapeutics PTCT:US USD -200341000 132.15M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Roche Holding ROG:VX 5.93B 5.62B
Sarepta Therapeutics SRPT:US USD -109408000 147.39M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
Vertex Pharmaceuticals VRTX:US USD 1.03B 93.2M